InCarda Therapeutics

We are a biopharmaceutical company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route.

[InCarda Therapeutics @InCardaThera]

The RESTORE-1 study for Atrial Fibrillation (AF) is actively recruiting patients diagnosed with AF for participation. You can access study related information and find a participating hospital near you at:
https://t.co/PdVNtMQTM1

[StopAfib.org @stopafib]

Participate in atrial fibrillation (#afib) patient advocacy training program. US candidates only. Please share, @nmarrouche @natale_md @aalahmadmd @LuigiDiBiaseMD
https://t.co/jdVYgTG1W8

[InCarda Therapeutics @InCardaThera]

We want to welcome Robert Lisicki to the InCarda Therapeutics family as our new CEO and Board Member.

And, we want to thank Grace Colón for nearly a decade of dedication to InCarda and patients living with atrial fibrillation.

https://t.co/pa13Q86pr1

[InCarda Therapeutics @InCardaThera]

Proud of our very own @ColonGraceE for being recognized by @CABiotech!

[California Biotech @CABiotech]

This #HispanicHeritageMonth, we recognize Grace E. Colón. @ColonGraceE, the President and Chief Executive Officer of InCarda Therapeutics, Inc. who brings years of experience in biopharma, genomics, healthcare, and industrial biotechnology. https://t.co/t8lZSeE7k6

[StopAfib.org @stopafib]

Consider joining us for Restoring Life’s Rhythm Webinars with Drs. Al-Ahmad (@aalahmadmd) & Colombowala (@RhythmMD). Hosted by #Medtronic for #AfibAwarenessMonth #atrialfibrillation #cardiacablation #heartmonitoring Please share

https://t.co/DCVbIcrAD0

[StopAfib.org @stopafib]

Help patients learn about the role of rhythm control in managing #afib. #AfibMonth #AfibAwarenessMonth #CardioTwitter #ePeeps #atrialfibrillation @EPrystowskyonEP
@DebbeMcCall @HRSonline @HeartRhythmTV @natale_md Please share

[Debbe McCall @DebbeMcCall]

Apple adds new atrial fibrillation feature to watchOS 9
It tracks the amount of time you spend in #Afib https://t.co/GyK48bogVU

[StopAfib.org @stopafib]

September is National Atrial Fibrillation Awareness Month! Help patients learn about the importance of getting in rhythm & staying in rhythm.
#StopAfib #AfibAwarenessMonth @DebbeMcCall #CardioTwitter #ePeeps #afib #atrialfibrillation #AfibMonth https://t.co/E1t0XUcoxW

[InCarda Therapeutics @InCardaThera]

We presented additional Phase 2 data on oral inhaled flecainide for acute cardioversion of paroxysmal atrial fibrillation at ESC last month!
#afib #epeeps #innovation #biotech

https://t.co/WM0Ytjg9Zm

[InCarda Therapeutics @InCardaThera]

Today marks the start of National Atrial Fibrillation Awareness Month.
At InCarda, we are driven by our desire to help empower patients living with AFib to have more control over their disease.
#afibmonth22 #EPeeps #stopafib #afib

[InCarda Therapeutics @InCardaThera]

Another awesome patient conference from @stopafib in the books! Very informative content presented by world-class providers. Some highlights: treatment options for AF, importance of rhythm control and the role of health tech in AF and drug monitoring.
#stopafib22 #epeeps

[InCarda Therapeutics @InCardaThera]

We’re excited to be here live in Dallas to support patients living with atrial fibrillation! Kudos to the StopAFib team! @MelanieHills #stopafib22

[InCarda Therapeutics @InCardaThera]

@A_Robinson1107 @OhioHealth @AnishAminEP @beth_loe @SreeBillakanty @badinmd @megan_labreck Kudos and gratitude to @A_Robinson1107 and @AnishAminEP and the entire team at @OhioHealth Afib Clinic!

[Andrea Robinson @A_Robinson1107]

So proud of this team right here! @OhioHealth #AfibClinic reaching the 5K patient milestone. Truly going above and beyond to deliver excellent #teambasedcare for our patients! @AnishAminEP @beth_loe @SreeBillakanty @badinmd @megan_labreck #EPeeps #teamworkmakesthedreamwork

[InCarda Therapeutics @InCardaThera]

We are excited to share that the first patient has been enrolled into our Phase 3 RESTORE-1 pivotal study. A huge milestone for InCarda and for patients with atrial fibrillation that we hope to serve!
https://t.co/xhGFr0VOKL
#innovative #EPeeps

[InCarda Therapeutics @InCardaThera]

We will be there! #Stopafib22

[StopAfib.org @stopafib]

Last Call: Early Bird Registration (save $30) for Get in Rhythm. Stay in Rhythm. Atrial Fibrillation Patient Conference (Dallas or livestream). #StopAfib22 @DebbeMcCall @elizgreene @S_NarayanMD @VivekReddyMD

https://t.co/D937YnMtvs

[InCarda Therapeutics @InCardaThera]

ICYMI: We presented some exciting data over the weekend at this years #HRS2022
https://t.co/q5xq3K1pab

[Warriors on NBCS @NBCSWarriors]

This angle of GP2’s poster dunk 😳

[InCarda Therapeutics @InCardaThera]

We are so enjoying #HRS2022 here in our backyard of San Francisco! We hope all our #EPeeps are too. In case you missed it today, we were very excited to present results of our INSTANT P2 study!

[InCarda Therapeutics @InCardaThera]

We are excited to announce publication of our Phase 2 INSTANT study results in @CircAHA. Even more flattering is that the publication was "Editor's Pick" for this edition! #Epeeps #atrialfibrillation #afib #biotech #pharmaceuticals Check it out: https://t.co/sY82hKLpcR